99 related articles for article (PubMed ID: 8470275)
1. Cardiac graft arteriosclerosis in the rat.
Adams DH; Wyner LR; Karnovsky MJ
Transplant Proc; 1993 Apr; 25(2):2071-3. PubMed ID: 8470275
[No Abstract] [Full Text] [Related]
2. Inhibition of graft arteriosclerosis by modulation of the inflammatory response.
Adams DH; Wyner LR; Steinbeck MJ; Karnovsky MJ
Transplant Proc; 1993 Apr; 25(2):2092-4. PubMed ID: 8470282
[No Abstract] [Full Text] [Related]
3. Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat.
Paul LC; Davidoff A; Benediktsson H
Transplant Proc; 1994 Oct; 26(5):2873-4. PubMed ID: 7940907
[No Abstract] [Full Text] [Related]
4. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
[No Abstract] [Full Text] [Related]
5. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
[No Abstract] [Full Text] [Related]
6. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.
Meiser BM; Wenke K; Thiery J; Wolf S; Devens C; Seidel D; Hammer C; Billingham ME; Reichart B
Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363
[No Abstract] [Full Text] [Related]
8. FK 506 inhibits the development of transplant arteriosclerosis.
Wu GD; Cramer DV; Chapman FA; Cajulis E; Wang HK; Starzl TE; Makowka L
Transplant Proc; 1991 Dec; 23(6):3272-4. PubMed ID: 1721433
[No Abstract] [Full Text] [Related]
9. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
[TBL] [Abstract][Full Text] [Related]
10. Does endotoxin accelerate rejection in a cardiac allograft model?
Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
[No Abstract] [Full Text] [Related]
11. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
[No Abstract] [Full Text] [Related]
12. Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors.
Schmid C; Heemann U; Azuma H; Tilney NL
Transplant Proc; 1995 Jun; 27(3):2077-9. PubMed ID: 7792891
[No Abstract] [Full Text] [Related]
13. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
Paul LC; Davidoff A; Benediktsson H; Issekutz TB
Transplantation; 1993 May; 55(5):1196-9. PubMed ID: 8497903
[No Abstract] [Full Text] [Related]
15. Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy.
Funeshima-Fuji N; Fujino M; Xie L; Kimura H; Takahara S; Ezaki T; Zhu BT; Li XK
J Heart Lung Transplant; 2009 Feb; 28(2):176-82. PubMed ID: 19201344
[TBL] [Abstract][Full Text] [Related]
16. Effects of interferon alpha/beta on cardiac allografts.
Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
[No Abstract] [Full Text] [Related]
17. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
18. Coronary arteriosclerosis did not occur in the transplanted hearts of tolerance-induced rats: analysis from platelet-derived growth factor expression.
Ito H; Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
Transplant Proc; 1998 Nov; 30(7):3871-2. PubMed ID: 9838694
[No Abstract] [Full Text] [Related]
19. Effect of intraportal injection of hepatic nonparenchymal cells on tolerance induction to heart allografts in the rat.
Lee SK; Perez-Atayde A; Vacanti JP; Lund DP
Transplant Proc; 1996 Jun; 28(3):1385-6. PubMed ID: 8658706
[No Abstract] [Full Text] [Related]
20. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
